2Weaver W D, Simes R J, Betriu A, et al. Comparisom of primary covorary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a guantitative review[J]. JAMA, 1997, 278(23): 2093.
3Grines C L, Browne K F, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group[J]. N Engl J Med, 1993, 328(10): 673.
4Grines C, Patel A, Zijlstra F, et al. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials[J]. Am Heart J, 2003, 145(1): 47.
5Costantini C O, Stone G W. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction[1] . J Am Coll Cardiol, 2004, 44(2): 305.
9[7]Gottlieb SS,Skettino SL,Wolf A,et al.Effects of BG9719 (CVT-124),an A1-adenosine receptor antagonist,and furosemide on glomerular fil-ationrate and natriuresis in patients with congestive heart failure[J].J Am Coll Cardiol,2000,35(1):56-59.
10[8]Patterson TM,Hendrfick JW,Sample JA,et al.Selective A1 receptor antagonism improve renal function in heart failure[J].Circulation,2000,102 Suppl 2:757.
